Correspondence (letter to the editor): One-sided publication
- PMID: 24078849
- PMCID: PMC3784033
- DOI: 10.3238/arztebl.2013.0609b
Correspondence (letter to the editor): One-sided publication
Comment in
-
Correspondence (reply): In reply.Dtsch Arztebl Int. 2013 Sep;110(37):610-1. doi: 10.3238/arztebl.2013.0610c. Dtsch Arztebl Int. 2013. PMID: 24078852 Free PMC article. No abstract available.
Comment on
-
The diagnosis and treatment of generalized anxiety disorder.Dtsch Arztebl Int. 2013 Apr;110(17):300-9; quiz 310. doi: 10.3238/arztebl.2013.0300. Epub 2013 Apr 26. Dtsch Arztebl Int. 2013. PMID: 23671484 Free PMC article.
References
-
- Schwan S, Sundström A, Stjernberg E, et al. A signal for an abuse liability for pregabalin results from the Swedish spontaneous adverse drug reaction reporting system. Eur J Clin Pharmacol. 2010;66:947–953. - PubMed
-
- Caster O, Edwards IR, Noren G0N, Lindquist M. Earlier discovery of pregabalin’s dependence potential might have been possible. Eur J Clin Pharmacol. 2011;673:19–20. - PubMed
-
- Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical